MedTrace Logo

Prediction of Hepatitis C Recurrence in Liver Transplant Recipients

NCT00867243 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2013-06-11

No results posted yet for this study

Summary

The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the order for the recipient to participate in the study. We will take blood samples from these patients and their donors.

Conditions

  • Complication of Transplanted Liver
  • Hepatitis C, Chronic

Sponsors & Collaborators

Principal Investigators

  • Talia Baker, MD · Northwestern Memorial Hospital

  • Anat Tambur, MD, PhD · Northwestern University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2010-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00867243 on ClinicalTrials.gov